Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (11-20 of 334) with videos related to

Pageof 34
Sort By:
Zeitschrift Fur Rheumatologie|August 13, 2010
[Non-TNF biologicals in therapy]Jürgen Wollenhaupt, Gerd-R Burmester
Current Opinion in Rheumatology|March 31, 2011
(R)evolution of clinical therapeutics and strategiesThomas Dörner, Gerd R Burmester
Nature Clinical Practice. Rheumatology|August 26, 2006
Can engineered cartilage transplants be used for treating rheumatic diseases?Michael Sittinger, Gerd R Burmester
Current Opinion in Rheumatology|April 23, 2003
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targetsThomas Dörner, Gerd R Burmester
Zeitschrift Fur Rheumatologie|June 3, 2026
Gerd R Burmester, Martin Krusche
The Lancet. Rheumatology|January 22, 2024
Obexelimab in IgG4-related disease: B-cell inhibition as a novel therapeutic approachTobias Alexander, Gerd R Burmester
Nature Reviews. Rheumatology|July 8, 2016
Rheumatoid arthritis: Glucocorticoid therapy and body compositionFrank Buttgereit, Gerd R Burmester
Nature Clinical Practice. Rheumatology|March 3, 2009
Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?Eugen Feist, Gerd-R Burmester
Expert Opinion on Biological Therapy|October 20, 2010
Canakinumab for treatment of cryopyrin-associated periodic syndromeEugen Feist, Gerd R Burmester
The New England Journal of Medicine|October 14, 2020
PRIME Cells Predicting Rheumatoid Arthritis FlaresThomas Dörner, Gerd R Burmester
Pageof 34

Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Zeitschrift Fur Rheumatologie|August 13, 2010
[Non-TNF biologicals in therapy]Jürgen Wollenhaupt, Gerd-R Burmester
Current Opinion in Rheumatology|March 31, 2011
(R)evolution of clinical therapeutics and strategiesThomas Dörner, Gerd R Burmester
Nature Clinical Practice. Rheumatology|August 26, 2006
Can engineered cartilage transplants be used for treating rheumatic diseases?Michael Sittinger, Gerd R Burmester
Current Opinion in Rheumatology|April 23, 2003
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targetsThomas Dörner, Gerd R Burmester
Zeitschrift Fur Rheumatologie|June 3, 2026
Gerd R Burmester, Martin Krusche
The Lancet. Rheumatology|January 22, 2024
Obexelimab in IgG4-related disease: B-cell inhibition as a novel therapeutic approachTobias Alexander, Gerd R Burmester
Nature Reviews. Rheumatology|July 8, 2016
Rheumatoid arthritis: Glucocorticoid therapy and body compositionFrank Buttgereit, Gerd R Burmester
Nature Clinical Practice. Rheumatology|March 3, 2009
Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?Eugen Feist, Gerd-R Burmester
Expert Opinion on Biological Therapy|October 20, 2010
Canakinumab for treatment of cryopyrin-associated periodic syndromeEugen Feist, Gerd R Burmester
The New England Journal of Medicine|October 14, 2020
PRIME Cells Predicting Rheumatoid Arthritis FlaresThomas Dörner, Gerd R Burmester
Pageof 34